GRI Bio, Inc. GRI Q1 2026 earnings
Reported May 13, 2026 · Before market open
EPS-$1.61Miss by $0.70
EPS estimate-$0.91
Next report
Aug 13, 2026 (In 2 weeks)EPS estimate-$1.20
Versus estimates
Revenue
Diluted EPS
Q1 2026-$1.61Miss by $0.70
Q1 2026-$13.25Beat by $16.02
Q4 2025-$35.85Miss by $4.76Q2 2025-$1.31In lineQ4 2024-$5.80Miss by $1.69Q4 2024-$319.73Ask the moment GRI Bio, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did GRI Bio, Inc. report Q1 2026 earnings?
- GRI Bio, Inc. (GRI) reported Q1 2026 earnings on May 13, 2026 before market open.
- What were GRI Bio, Inc.'s Q1 2026 revenue and EPS?
- GRI Bio, Inc. reported eps of $-1.61 for Q1 2026.
- Did GRI Bio, Inc. beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.91 by $0.70.
- Where can I find GRI Bio, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001824293-26-000046) and the 10-Q periodic report (0001824293-26-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.